These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 8077800

  • 1. The effect of exogenous phosphocreatine on maximal walking distance, blood rheology, platelet aggregation, and fibrinolysis in patients with intermittent claudication.
    Panchenko E, Dobrovolsky A, Rogoza A, Sorokin E, Ageeva N, Markova L, Titaeva E, Anuchin V, Karpov Y, Saks V.
    Int Angiol; 1994 Mar; 13(1):59-64. PubMed ID: 8077800
    [Abstract] [Full Text] [Related]

  • 2. [Positive effect of intermittent overpressure and underpressure (Vacusac) in intermittent claudication].
    Mehlsen J, Himmelstrup H, Himmelstrup B, Winther Hansen KF.
    Ugeskr Laeger; 1994 Jan 10; 156(2):169-71. PubMed ID: 8296403
    [Abstract] [Full Text] [Related]

  • 3. Observations on changes in intermittent claudication after the administration of creatine phosphate.
    Favilli S, Iacopetti L, Fradella GA, Righi D, Nuzzaci G.
    Pharmatherapeutica; 1982 Jan 10; 3(4):221-6. PubMed ID: 7146037
    [Abstract] [Full Text] [Related]

  • 4. A preliminary study on the effects of exercising to maximum walking distance on platelet and endothelial function in patients with intermittent claudication.
    Collins P, Ford I, Ball D, Macaulay E, Greaves M, Brittenden J.
    Eur J Vasc Endovasc Surg; 2006 Mar 10; 31(3):266-73. PubMed ID: 16360327
    [Abstract] [Full Text] [Related]

  • 5. Clinical and hemorheological effects of buflomedil in diabetic subjects with intermittent claudication.
    Diamantopoulos EJ, Grigoriadou M, Ifanti G, Raptis SA.
    Int Angiol; 2001 Dec 10; 20(4):337-44. PubMed ID: 11782701
    [Abstract] [Full Text] [Related]

  • 6. [Flunarizine in the treatment of arteriopathies of the legs].
    Catalano M, Sacchi E, Tomasini M, Coazzoli E, Parolini A, Dall'Oglio A, Libretti A.
    Ric Clin Lab; 1985 Dec 10; 15 Suppl 1():475-8. PubMed ID: 4035228
    [Abstract] [Full Text] [Related]

  • 7. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities].
    Maksimović ZV.
    Srp Arh Celok Lek; 1999 Dec 10; 127(7-8):249-53. PubMed ID: 10624398
    [Abstract] [Full Text] [Related]

  • 8. [Padma-28, a herbal preparation, increases walking distance in patients with intermittent claudication].
    Drabaek H, Mehlsen J, Petersen JR, Himmelstrup H, Hansen KF.
    Ugeskr Laeger; 1994 Oct 17; 156(42):6207-9. PubMed ID: 7998359
    [Abstract] [Full Text] [Related]

  • 9. Trial of a novel prostacyclin analog, UT-15, in patients with severe intermittent claudication.
    Mohler ER, Klugherz B, Goldman R, Kimmel SE, Wade M, Sehgal CM.
    Vasc Med; 2000 Oct 17; 5(4):231-7. PubMed ID: 11213235
    [Abstract] [Full Text] [Related]

  • 10. Effect of the oral hypoglycaemic sulphonylurea glibenclamide, a blocker of ATP-sensitive potassium channels, on walking distance in patients with intermittent claudication.
    Mortensen UM, Nielsen-Kudsk JE, Sondergaard HM, Jakobsen P, Jensen BS, Schmitz O, Nielsen TT.
    Diabet Med; 2006 Mar 17; 23(3):327-30. PubMed ID: 16492219
    [Abstract] [Full Text] [Related]

  • 11. Anti-chlamydial antibiotic therapy for symptom improvement in peripheral artery disease: prospective evaluation of rifalazil effect on vascular symptoms of intermittent claudication and other endpoints in Chlamydia pneumoniae seropositive patients (PROVIDENCE-1).
    Jaff MR, Dale RA, Creager MA, Lipicky RJ, Constant J, Campbell LA, Hiatt WR.
    Circulation; 2009 Jan 27; 119(3):452-8. PubMed ID: 19139383
    [Abstract] [Full Text] [Related]

  • 12. Prevention by NCX 4016, a nitric oxide-donating aspirin, but not by aspirin, of the acute endothelial dysfunction induced by exercise in patients with intermittent claudication.
    Gresele P, Migliacci R, Procacci A, De Monte P, Bonizzoni E.
    Thromb Haemost; 2007 Mar 27; 97(3):444-50. PubMed ID: 17334512
    [Abstract] [Full Text] [Related]

  • 13. Effects of policosanol (10 mg/d) versus aspirin (100 mg/d) in patients with intermittent claudication: a 10-week, randomized, comparative study.
    Illnait J, Castaño G, Alvarez E, Fernández L, Mas R, Mendoza S, Gamez R.
    Angiology; 2008 Mar 27; 59(3):269-77. PubMed ID: 18388038
    [Abstract] [Full Text] [Related]

  • 14. Treatment of intermittent claudication with pentoxifylline: a 12-month, randomized trial--walking distance and microcirculation.
    De Sanctis MT, Cesarone MR, Belcaro G, Nicolaides AN, Griffin M, Incandela L, Bucci M, Geroulakos G, Ramaswami G, Vasdekis S, Agus G, Bavera P, Ippolito E.
    Angiology; 2002 Mar 27; 53 Suppl 1():S7-12. PubMed ID: 11865838
    [Abstract] [Full Text] [Related]

  • 15. Studies on haematocrit in peripheral arterial disease.
    Lowe GD, Saniabadi A, Turner A, Lieberman P, Pollock J, Drury J.
    Klin Wochenschr; 1986 Oct 01; 64(19):969-74. PubMed ID: 3784449
    [Abstract] [Full Text] [Related]

  • 16. The relationship between ankle-brachial index and leisure-time physical activity in patients with intermittent claudication.
    Gardner AW, Clancy RJ.
    Angiology; 2006 Oct 01; 57(5):539-45. PubMed ID: 17067975
    [Abstract] [Full Text] [Related]

  • 17. Acute impairment of the endothelial function by maximal treadmill exercise in patients with intermittent claudication, and its improvement after supervised physical training.
    Andreozzi GM, Leone A, Laudani R, Deinite G, Martini R.
    Int Angiol; 2007 Mar 01; 26(1):12-7. PubMed ID: 17353883
    [Abstract] [Full Text] [Related]

  • 18. The effect of a combined administration of ridogrel and ketanserin in patients with intermittent claudication.
    De Cree J, Geukens H, Gutwirth P, De Clerck F, Vercammen E, Verhaegen H.
    Int Angiol; 1993 Mar 01; 12(1):59-68. PubMed ID: 8376914
    [Abstract] [Full Text] [Related]

  • 19. Effect of low-density lipoprotein apheresis on patients with peripheral arterial disease. Peripheral Arterial Disease LDL Apheresis Multicenter Study (P-LAS).
    Tsuchida H, Shigematsu H, Ishimaru S, Iwai T, Akaba N, Umezu S.
    Int Angiol; 2006 Sep 01; 25(3):287-92. PubMed ID: 16878078
    [Abstract] [Full Text] [Related]

  • 20. Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease.
    Mohler ER, Hiatt WR, Creager MA.
    Circulation; 2003 Sep 23; 108(12):1481-6. PubMed ID: 12952839
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.